Ventilator-Associated Pneumonia (VAP) Clinical Trials

10 recruitingLast updated: June 18, 2026

There are 10 actively recruiting ventilator-associated pneumonia (vap) clinical trials across 9 countries. Studies span Not Applicable, Phase 4. Top locations include Beijing, Beijing Municipality, China, Hangzhou, Zhejiang, China, Argenteuil, France, France. Updated daily from ClinicalTrials.gov.


Ventilator-Associated Pneumonia (VAP) Trials at a Glance

10 actively recruiting trials for ventilator-associated pneumonia (vap) are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Hangzhou, and Argenteuil. Lead sponsors running ventilator-associated pneumonia (vap) studies include Asian Institute of Gastroenterology, India, Hiroshima University, and Affiliated Hospital of Nantong University.

Browse ventilator-associated pneumonia (vap) trials by phase

About Ventilator-Associated Pneumonia (VAP) Clinical Trials

Looking for clinical trials for Ventilator-Associated Pneumonia (VAP)? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ventilator-Associated Pneumonia (VAP) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ventilator-Associated Pneumonia (VAP) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways

Ventilator-Associated Pneumonia (VAP)Microbiome DysbiosisIntensive Care Unit (ICU) Patients
Jian-Xin Zhou220 enrolled3 locationsNCT07129174
Recruiting

Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderly Patients

Ventilator-Associated Pneumonia (VAP)Intubated ICU PatientsImmunoparalysis
Hospital Universitari de Bellvitge170 enrolled1 locationNCT07551258
Recruiting
Not Applicable

Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial

Ventilator-Associated Pneumonia (VAP)
Qilu Hospital of Shandong University508 enrolled1 locationNCT06834971
Recruiting
Not Applicable

Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

Ventilator-Associated Pneumonia (VAP)
Nantes University Hospital686 enrolled41 locationsNCT06743529
Recruiting

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Ventilator-Associated Pneumonia (VAP)Hospital Acquired Pneumonia (HAP)Complicated Intra-Abdominal Infections, cIAIs
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT07268560
Recruiting

National Surveillance and Prevention of Neonatal VAP

Bronchopulmonary Dysplasia (BPD)Ventilator-Associated Pneumonia (VAP), NeonatalAntibiotic-Resistant Organisms (AROs)+1 more
University of Alberta1,500 enrolled1 locationNCT07109791
Recruiting
Not Applicable

Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients

Ventilator-Associated Pneumonia (VAP)Mechanical Ventilation Pressure HighRespiratory Depression Neonatal
Affiliated Hospital of Nantong University258 enrolled3 locationsNCT07375667
Recruiting
Not Applicable

Effect of Implementing Evidence-based Practice and Nurse's Behavior Change on Quality of Care in Intensive Care Unit: Focus on Ventilator Associated Pneumonia in a Tertiary Hospital in Bangladesh

Ventilator-Associated Pneumonia (VAP)Evidence-Based Practice
Hiroshima University272 enrolled2 locationsNCT06624540
Recruiting

Pre-clinical Diagnosis Using Integrated Microbial and Host Response Signatures to Improve Outcomes From Ventilator-associated Pneumonia in Critically Ill Children

Ventilator-Associated Pneumonia (VAP)
University of Cambridge300 enrolled1 locationNCT07026656
Recruiting
Phase 4

A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis

CirrhosisVentilator-Associated Pneumonia (VAP)Hepatic Encephalopathy
Asian Institute of Gastroenterology, India162 enrolled2 locationsNCT06808074